Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
16-30 of 410
Advanced Urothelial Carcinoma: Optimizing Second-Line Care
Project Oncology®Advanced Urothelial Carcinoma: Optimizing Second-Line Care
Guru P. Sonpavde, MD
The Art of Treatment Sequencing in Advanced Urothelial Carcinoma
Project Oncology®The Art of Treatment Sequencing in Advanced Urothelial Carcinoma
Guru P. Sonpavde, MD
Urine RNA Panel Supports Less Invasive Bladder Cancer Surveillance
Project Oncology®Urine RNA Panel Supports Less Invasive Bladder Cancer Surveillance
Can AI Imaging Improve Risk Stratification in Upper Tract Urothelial Carcinoma?
Project Oncology®Can AI Imaging Improve Risk Stratification in Upper Tract Urothelial Carcinoma?
Exploring Treatment Strategies in epNEC: The Emerging Role of DLL3
Project Oncology®Exploring Treatment Strategies in epNEC: The Emerging Role of DLL3
Charles Turck, PharmD, BCPS, BCCCP
Jason Starr, DO
Overcoming Clinical Inertia to Individualize Myelofibrosis Treatment
Project Oncology®Overcoming Clinical Inertia to Individualize Myelofibrosis Treatment
Alexandria May, PharmD, BCPS
Prithviraj Bose, MD
- advertisement
Applying Clinical Trial Data in mCSPC Care
Project Oncology®Applying Clinical Trial Data in mCSPC Care
Steve Jackson, PharmD
Jahan Aghalar, MD
Ulka Vaishampayan, MD
Personalizing Long-Term mCSPC Treatment Decisions
Project Oncology®Personalizing Long-Term mCSPC Treatment Decisions
Charles Turck, PharmD, BCPS, BCCCP
Bilal Siddiqui, MD
Evidence-Based Treatment Decisions in Metastatic Triple-Negative Breast Cancer
Project Oncology®Evidence-Based Treatment Decisions in Metastatic Triple-Negative Breast Cancer
Alexandria May, PharmD, BCPS
Neil M. Iyengar, MD
Interpreting and Applying cGVHD Clinical Trial Data
Project Oncology®Interpreting and Applying cGVHD Clinical Trial Data
Charles Turck, PharmD, BCPS, BCCCP
Christopher Graham, MD
Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Project Oncology®Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Jorge Nieva, MD
Evolving Treatment Strategies in ALK+ Non-Small Cell Lung Cancer
Project Oncology®Evolving Treatment Strategies in ALK+ Non-Small Cell Lung Cancer
Jorge Nieva, MD
- advertisement
Comprehensive Molecular Testing in ALK+ Non-Small Cell Lung Cancer
Project Oncology®Comprehensive Molecular Testing in ALK+ Non-Small Cell Lung Cancer
Urs Weber, MD
Side Effect Management in ALK+ Non-Small Cell Lung Cancer Care
Project Oncology®Side Effect Management in ALK+ Non-Small Cell Lung Cancer Care
Urs Weber, MD
Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Project Oncology®Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Urs Weber, MD
